MSc in Precision Cancer Medicine
What is the course about?
Precision medicine is an emerging approach which takes into account variability in the biology, environment, and lifestyle for each individual person to help guide disease diagnosis and treatment. In particular, genetic and genomic data allow us to go beyond conventional histopathological assessment, and classify cancer into distinct sub-entities that guide our choice of the right treatment to the right patient at the right time.
In order to make precision medicine a reality, the clinical development of diagnostics and therapeutics need to go hand in hand. Future leaders, whether in research or in the clinic, will need a broad understanding of the field and an ability to work with a range of stakeholders.
The new MSc in Precision Cancer Medicine was conceived to meet this need and was developed by Professor Sarah Wordsworth, (Nuffield Department of Population Health), and Associate Professor Anna Schuh, (Department of Oncology). The vision for the course is to equip our graduates with a multi-disciplinary understanding, beyond their own area of expertise, and to prepare them for leadership roles at the forefront of cancer medicine.
Who is the course for?
The course will appeal to health professionals from a variety of backgrounds including:
- clinical academics;
- scientists and clinicians from both academia and industry;
- scientists and clinicians working in all stages of target discovery and drug development.